A predictive survival model for patients with stage IV oropharyngeal squamous cell carcinoma treated with chemoradiation
ConclusionsThe pretreatment Hb, pretreatment SII, posttreatment SII, and posttreatment SIRI are associated with survival in patients with stage IV oropharyngeal cancers. The developed nomogram aids in survival prediction and treatment adjustment.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | ENT & OMF | HIV AIDS | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nutrition | Oropharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study